Accutane (isotretinoin) works primarily by triggering programmed cell death in the oil-producing glands of your skin, shrinking them dramatically and cutting off the conditions that acne needs to thrive. It’s the most effective treatment available for severe acne, with roughly 77.5% of patients staying clear after a single course. But unlike antibiotics or topical treatments that target one piece of the acne puzzle, isotretinoin attacks nearly every factor involved: oil production, bacterial growth, inflammation, and pore clogging.
How It Shrinks Oil Glands
The core mechanism behind isotretinoin is something called apoptosis, which is the body’s natural process for eliminating unwanted cells. Once you take the drug, it reaches the sebaceous (oil) glands in your skin, where it gets converted into a more active form of vitamin A. This active form switches on a chain of molecular signals that essentially tell oil gland cells to self-destruct.
Specifically, the drug activates a protein called FoxO3a, which acts as a master switch for cell death. FoxO3a triggers a molecule called TRAIL, which kicks off a cascade that dismantles oil gland cells from the inside. At the same time, a related protein called FoxO1 puts the brakes on cell division, preventing new oil gland cells from replacing the ones being destroyed. The result is a significant reduction in both the size and metabolic activity of your oil glands. With far less sebum (oil) being produced, the conditions that fuel acne breakouts collapse.
How Reduced Oil Starves Acne Bacteria
Isotretinoin isn’t an antibiotic, yet it dramatically reduces the population of Cutibacterium acnes, the bacterium most closely linked to inflammatory breakouts. It does this indirectly by transforming the environment those bacteria depend on.
C. acnes thrives on the lipids in sebum. When isotretinoin slashes oil production, it essentially removes the bacteria’s food supply. The skin shifts from an oily environment to a much drier one, creating selective pressure that many bacterial strains can’t survive. Research using genetic analysis of the skin microbiome found that after 20 weeks of treatment, the bacteria that remained showed significantly reduced activity in four critical metabolic pathways: amino acid production, histidine metabolism, folate production, and DNA building. These pathways are essential for rapidly dividing cells, meaning the surviving microbes had a limited ability to grow or reproduce. It’s less like killing bacteria with a drug and more like salting the earth so they can’t flourish.
Its Effect on Inflammation
Acne isn’t just about clogged pores and bacteria. It’s an inflammatory condition, and isotretinoin addresses that directly. The drug reduces the activity of immune cells called neutrophils and monocytes, which are the first responders that rush to a clogged pore and cause the redness, swelling, and pain of a deep breakout. It does this partly by lowering levels of a receptor (TLR2) that these immune cells use to detect bacteria and mount an inflammatory response.
Studies tracking patients over 24 weeks of treatment have found significant drops in white blood cell counts, neutrophil levels, and several key inflammatory signaling molecules, including TNF-alpha, IL-17, and interferon-gamma. Platelet and monocyte counts also decrease. These changes suggest isotretinoin doesn’t just calm inflammation at the skin’s surface. It dials down systemic inflammation throughout the body, which helps explain why patients often see improvement in overall skin tone and redness beyond their active breakouts.
What a Typical Course Looks Like
A standard course of isotretinoin lasts four to five months. Most prescribers aim for a cumulative dose in the range of 120 to 220 mg/kg of body weight over the full course, because reaching a sufficient total dose is the strongest predictor of long-term clearance. The daily dose can be adjusted based on how well you tolerate side effects, since research shows that what matters most is the total amount you take over time, not how much you take on any given day. This gives flexibility: a lower daily dose taken over a longer period can be just as effective as a higher daily dose over a shorter one.
Many people experience an initial flare during the first month or two, where acne temporarily worsens before improving. This is common and happens because the drug accelerates turnover in the skin before things settle down. Dermatologists can often manage this flare with short-term add-on treatments if it’s severe.
Common Side Effects and Their Frequency
Because isotretinoin suppresses oil production throughout your body (not just your face), dryness is by far the most common experience. A large meta-analysis pooling data from thousands of patients found the following rates:
- Dry, chapped lips: about 58% of patients
- Dry skin: about 49%
- Cheilitis (cracking at the corners of the mouth): about 42%
- Joint pain: about 17%
Lip balm and moisturizer become daily essentials. Joint pain, when it occurs, tends to be mild and concentrated in areas like the lower back and knees, particularly in physically active patients. These side effects are dose-dependent and reversible once the course ends.
Blood Monitoring During Treatment
Isotretinoin can temporarily raise cholesterol and liver enzymes in some patients, so blood work is part of the process. Current guidelines recommend a liver panel and lipid panel before starting treatment, then again one to two months in. If those results come back normal, follow-up testing every six months is generally sufficient for the rest of the course. This is a less aggressive monitoring schedule than older guidelines, which called for testing every three months, but recent evidence suggests that patients with normal early results rarely develop problems later.
Long-Term Clearance and Relapse Rates
In a large cohort study of nearly 20,000 patients, about 22.5% experienced acne relapse after completing a course, and only 8.2% needed a second round of isotretinoin. That means roughly three out of four patients stay clear long-term after a single course.
A few factors influence your odds. Women had a higher rate of relapse than men, likely due to hormonal fluctuations that continue to affect oil production after treatment. Higher cumulative doses were associated with lower relapse rates, reinforcing why reaching the full target dose matters. Interestingly, patients who received very high cumulative doses (above 220 mg/kg) didn’t see additional relapse protection compared to those in the conventional range, suggesting there’s a ceiling to the benefit. For those who do relapse, a second course is typically just as effective as the first.